JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2022, 71(6):245-250 | DOI: 10.5817/CSF2022-6-245

Contribution to the concept of polypharmacy I. Etymological notes and characteristics

Jozef Kolář1,2, Tünde Ambrus1,*, Dominik Grega1, Lenka Smejkalová1,2
1 Masarykova univerzita, Farmaceutická fakulta, Ústav aplikované farmacie, Brno
2 Farmaceutická fakulta Univerzity Karlovy, Hradec Králové, Katedra sociální a klinické farmacie

The contribution captures three basic concepts of the term polypharmacy. The analysis of four bibliographic databases demonstrates the importance of the correct and uniform use of terminology. It also approximates the most common numerical expression of the level of polypharmacy and the most common extended terms of polypharmacy.

Keywords: definition; polypharmacy; etymology; characteristics; concepts
Grants and funding:

Práce byla podpořena grantem Masarykovy univerzity (MUNI/A/1246/2021).

Received: September 20, 2022; Accepted: October 1, 2022; Published: June 1, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kolář J, Ambrus T, Grega D, Smejkalová L. Contribution to the concept of polypharmacy I. Etymological notes and characteristics. Čes. slov. farm. 2022;71(6):245-250. doi: 10.5817/CSF2022-6-245.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Polypragmoneo. https://slovnik-cizich-slov.abz.cz/web.php/slovo/polypragmoneo
    2. Polypragmasy. https://medical-dictionary.thefreedictionary.com/polypragmasy
    3. Fedonyuk L. Ya., Oleshchuk A. M., Sas L. M., Boyarchuk O. R., Mikolenko A. Z., Oryol Yu. N., Glushko K. T. Polypragmasy: from paediatrics tо geriatrics. Vopr. prakt. pediatr. (Clinical Practice in Pediatrics) 2018; 13(1), 77-82. Go to original source...
    4. Polypharmacy. https://www.merriam-webster.com/dictionary/polypharmacy
    5. Polypharmacy. https://en.wiktionary.org/wiki/polypharmacy
    6. Ross S. M. Defining Polypharmacy and Understanding Its Risks and Benefits. https://blog.cureatr.com/defining-polypharmacy-and-understanding-its-risks-and-benefits
    7. Farmakos. https://cs.wikipedia.org/wiki/Farmakos
    8. Pharmakon (philosophy). https://en.wikipedia.org/wiki/Pharmakon_(philosophy)
    9. Belz G. G., Palm D. Paracelsus. Dtsch. Ärztebl. 1993; 90(22), A 1630-1631.
    10. Benzenhöfer U. In allen Bereichen begehrte er gegen die Autoritäten auf. Zum "500" Geburtstag des Theophrast von Hohenheim, genannt Paracelsus. Dtsch Ärztebl. 1993; 90(10, 12), 704-706.
    11. Khaitovych M. V. Polypharmacy: definition, risks, management. Oral and General Health 2021; 2(3), 7-12. Go to original source...
    12. Komjáthy H. Vplyv farmakoterapie na starších pacientov. Prakt. lekárn. 2020; 10(1-2), 13-16.
    13. Kriška M., Dukát A., Gajdošík J., Bernadič M. Polyfarmácia, polypragmázia, hyperpreskripcia - sú aj na Slovensku! Aktuálna úloha - depreskripcia. Monitor medicíny SLS 2020; 1-2, 5-9.
    14. Varghese D., Ishida C., Haseer Koya H. Polypharmacy. 2022 In: StatPearls [Internet]. Treasure Island (FL): Stat- Pearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK532953/#!po=5.55556
    15. Duerden M., Payne R. Polypharmacy - what is it and how common is it? Prescriber 2014; 25(21), 44-47. Go to original source...
    16. Newnham W. Remarks on the present aspect of medicine. Prov. Med. Surg. J. 1848; 12(11), 281-285. Go to original source... Go to PubMed...
    17. Polypharmacy. https://www.ncbi.nlm.nih.gov/mesh/?term=POLYPHARMACY
    18. A glossary of terms for Community Health Care and Services for Older Persons. WHO Centre for Health Development (Kobe, Japan)2004.
    19. Montamat S. C., Cusack B. Overcoming problems with polypharmacy and drug misuse in the elderly. Clin. Geriatr. Med. 1992; 8(1), 143-158. Go to original source...
    20. Masnoon N., Shakib S., Kalisch-Ellett L., Caughey G. E. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017; 17(1), 230. Go to original source... Go to PubMed...
    21. Bakaki P. M., Horace A., Dawson N., Winterstein A., Waldron J., Staley J., Pestana Knight E. M., Meropol S. B., Liu R., Johnson H., Golchin N., Feinstein J. A., Bolen S. D., Kleinman L. C. Defining pediatric polypharmacy: A scoping review. PLoS ONE 2018; 13(11), e0208047. Go to original source... Go to PubMed...
    22. Medication Safety in Polypharmacy. Geneva: World Health Organization 2019, 61 s. https://apps.who.int/iris/bitstream/handle/10665/325454/WHO-UHC-SDS-2019.11-eng.pdf?ua=1
    23. Taghy N., Cambon L., Cohen J.-M., Dussart C. Failure to Reach a Consensus in Polypharmacy Definition: An Obstacle to Measuring Risks and Impacts - Results of a Literature Review. Ther. Clin. Risk Manag. 2020; 16, 57-73. Go to original source... Go to PubMed...
    24. Duerden M., Avery T., Payn R. Polypharmacy and medicines optimisation. Making it safe and sound. The King's Fund 2013; 56 s. https://www.kingsfund.org.uk/publications/polypharmacy-and-medicines-optimisation
    25. Werder S. F., Preskorn S. H. Managing polypharmacy: Walking the fine line between help and harm. Curr. Psychiatr. 2003; 2(2), 24-36.
    26. Polypharmacy and Maslow theory. https://www.eddusaver.com/polypharmacy-and-maslow-theory/
    27. Scott I. A., Hilmer S. N., Reeve E., Potter K., Le Couteur D., Rigby D., Gnjidic D., Del Mar C. B., Roughead E. E., Page A., Jansen J., Martin J. H. Reducing inappropriate Polypharmacy. The Process of Deprescribing. JAMA Intern. Med. 2015; 175(5), 827-834. Go to original source... Go to PubMed...
    28. Bushardt R. L., Massey E. B., Simpson T. W., Ariail J. C., Simpson K. N. Polypharmacy: misleading, but manageable. Clin. Interv. Aging 2008; 3(2), 383-389. Go to original source... Go to PubMed...
    29. Bushardt R. L., Jones K. W. Nine key questions to address polypharmacy in the elderly. JAAPA 2005; 18(5), 32-37. Go to original source... Go to PubMed...
    30. Lee G. B., Etherton-Beer Ch., Hosking S. M., Pasco J. A., Page A. T. The patterns and implications of potentially suboptimal medicine regimens among older adults: a narrative review. Ther. Adv. Drug Saf. 2022; 13, 1-41. Go to original source... Go to PubMed...
    31. Scottish Government Model of Care Polypharmacy Working Group. Polypharmacy Guidance, Realistic Prescribing, 3rd edition, 2018. Scottish Government, 83 s. https://www.therapeutics.scot.nhs.uk/wp-content/uploads/2018/04/Polypharmacy-Guidance-2018.pdf
    32. Selph Ch., Cosca B. Less is More: Preventing Polypharmacy in Individuals with Intellectual Disabilities. https://publications.ici.umn.edu/impact/29-1/less-is-more-preventing-polypharmacy-in-individuals-with-intellectual-disabilities
    33. Bricker D. A., Metzger A. H. Reducing Polypharmacy: Prudent Prescribing in Primary Care. Primary Care Reports. September 1st, 2009. https://www.reliasmedia.com/articles/114063-reducing-polypharmacy-prudent-prescribing-in-primary-care
    34. Medication Without Harm - Global Patient Safety Challenge on Medication Safety. Geneva: World Health Organization 2017
    35. Farrell B. J., Jeffs L., Irving H., McCarthy L. M. Patient and provider perspectives on the development and resolution of prescribing cascades: a qualitative study. BMC Geriatr. 2020; 20, 368. Go to original source... Go to PubMed...
    36. Rochon P. A., Gurwitz J. H. Drug therapy. Lancet 1995; 346(8966), 32-36. Go to original source... Go to PubMed...
    37. Rochon P. A., Gurwitz J. H. Optimising drug treatment for elderly people: the prescribing cascade. BMJ 1997; 315(7115), 1096-1099. Go to original source... Go to PubMed...
    38. Rochon P. A., Gurwitz J. H. The prescribing cascade revisited. Lancet 2017; 389(10081), 1778-1780. Go to original source... Go to PubMed...
    39. Scott I., Anderson K., Freeman C. Review of structured guides for deprescribing. Eur. J. Hosp. Pharm. 2017; 24(1), 51-57. Go to original source...
    40. Scott I. A., Le Couteur D. G. Physicians need to take the lead in deprescribing. Intern. Med. J. 2015; 45(3), 352- 356. Go to original source... Go to PubMed...
    41. McCarthy L. M., Visentin J. D., Rochon P. A. Assessing the Scope and Appropriateness of Prescribing Cascades. J. Am. Geriatr. Soc. 2019; 67(5), 1023-1026. Go to original source... Go to PubMed...
    42. Mair A., Fernandez-Llimos F., Alonso A., Harrison C., Hurding S., Kempen T., Kinnear M., Michael N., McIntosh J., Wilson M. Polypharmacy Management by 2030: a patient safety challenge. 2nd edition Coimbra: SIMPATHY Consortium 2017.

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.